What would you say needs to happen to move those discoveries beyond the laboratory?

I believe that's a very important and critical question.

As Thomas indicated earlier, neuroscience, I think, is in a very exciting era of novel discoveries about the brain and its function.

But I believe that the key step is to build a translation pathway from discovery to implementation.

So rather than treating clinical translations as the final stage of research.

So this means that we need to validate promise and biomarkers for digital measures.

and treatment targets in diverse real-world patient populations, truly demonstrating that they improve meaningful clinical outcomes, and also establish how they can be incorporated into routine clinical workflows.

And Martin, where do you see the biggest barriers to translating neuroscience into innovation and into clinical practice?